Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Schering-Plough drug given Nice approval

Schering-Plough drug given Nice approval

3rd December 2007

The National Institute for Health and Clinical Excellence (Nice) has recommended the use of Ezetrol within the National Health Service.

Ezetrol, also known as ezetimibe, is made by Merck and Schering-Plough and can help patients who are struggling to reach their target cholesterol levels using a statin only.

Statins operate by inhibiting the production of cholesterol, while Zetia reduces the absorption of cholesterol in the intestine.

Nice has endorsed the drug for use on its own or in conjunction with a statin. It reports that as many as 150,000 people could benefit from the drug.

Andrew Dillon, chief executive of Nice, said: “Today’s guidance – is good news for those patients who are unable to achieve their target cholesterol levels using a statin alone.”

Furthermore, it is good news for healthcare professionals as it offers them a greater choice when treating patients at risk from their high levels of cholesterol, he continued.

Schering-Plough recently acquired Organon BioSciences, a firm dealing in human and animal health.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.